Abstract:BACKGROUND:The nature and the mechanism involved in the formation of the multinucleated giant cells (MGCs) in various giant cell-containing lesions of the jaws are not fully understood. The aim of this study is to clarify the osteoclastic features of the MGCs in central giant cell granuloma (CGCG), peripheral giant cell granuloma (PGCG), cherubism, and aneurysmal bone cyst (ABC), and the mechanism underlying the interrelations between cellular components in the formation of the MGCs.METHODS:Immunohistochemical study with a panel of antibodies including vacuolar H+-ATPase (V-ATPase), carbonic anhydrase II (CA II), Cathepsin K, matrix metalloproteinases-9 (MMP-9), CD68, and proliferating cell nuclear antigen (PCNA), and enzyme histochemical staining for tartarate-resistant acid phosphatase (TRAP) were applied on a total number of 53 cases of giant cell-containing lesions including CGCG (n = 34), PGCG (n = 6), cherubism (n = 7), and ABC (n = 6). In situ hybridization was also carried out to detect the mRNA expression of the receptor activator of NF-kappaB ligand (RANKL), a newly identified cytokine that is shown to be essential in the osteoclastogenesis, its receptor RANK (receptor activator of NF-kappaB ligand), and its decoy receptor OPG (osteoprotegerin) in these four types of lesions.RESULTS:Immunohistochemical and enzyme histochemical studies showed that both the MGCs and a fraction of mononuclear cells in these lesions were strongly positive for TRAP, V-ATPase, CA II, Cathepsin K, MMP-9, and CD68, while the spindle-shaped mononuclear cells were positive for PCNA. The results with in situ hybridization indicated that RANKL mRNA was mainly expressed in the spindle mononuclear cells while OPG was extensively distributed in both the MGCs and the mononuclear cells. RANK mRNA was expressed in the MGCs and some round mononuclear cells.CONCLUSIONS:These results suggest that MGCs in the four types of giant cell-containing lesions of the jaws show characteristics of the osteoclast phenotype. The mononuclear stromal cells, which show TRAP positively, may be the precursors of the MGCs. RANKL, OPG, and RANK expressed in these lesions may play important roles in the formation of the MGCs. The similar characteristics and mechanisms in the differentiation of MGCs in these lesions also suggest that there might be a similar kind of pathogenesis involved in the formation of the MGCs in these lesions

IN VITRO BONE RESORPTION INDUCED BY CULTURED MULTINUCLEATED GIANT CELLS ISOLATED FROM GIANT CELL TUMOUR

[Purification and Study of the Characteristics of the Multinucleated Giant Cells of the Giant Cell Tumor].

Effect of Cytokines on in Vitro Bone Resorption by Cells Isolated from Giant Cell Tumor of Bone.

Multinucleated Giant Cells in Various Forms of Giant Cell Containing Lesions of the Jaws Express Features of Osteoclasts.

[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Nature of multinucleated giant cells in giant cell tumor and giant cell granuloma of the jaws

Serglycin Induces Osteoclastogenesis and Promotes Tumor Growth in Giant Cell Tumor of Bone.

Downregulation of Mir-223 and Mir-19A Induces Differentiation and Promotes Recruitment of Osteoclast Cells in Giant-Cell Tumor of the Bone Via the Runx2/TWIST-RANK/RANKL Pathway

Biological characteristics of a novel giant cell tumor cell line derived from spine

Histological and immunohistochemical analyses of osteoclast maturation in giant cell tumor of bone

Giant cells and osteoclasts present in bone grafted with nacre differ by nuclear cytometry evaluated by texture analysis

Application of Cell Engineering of Herbal Medicine Treating Bone Resorption of Osteoclasts

Gene Expression of Osteoprotegerin and Osteoclast Differentiation Factor in Giant Cell Tumor

Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone

Three-dimensional coculture system for osteoclasts

[Comparison of Two Methods of Isolation and Culture of Osteoclasts and the Dynamic Observation of Bone Resorption].

Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone

<TITLE>BONE MARROW STROMAL CELLS(BMSC)AND BONE MARROW MONOCYTES COMBINED TO INDUCE OSTEOCLAST CELLS

Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone

Giant cell tumor of bone revisited

Factors related to biologic behavior in giant cell tumor of bone